Document:

EX-10.5

 Exhibit 10.5 

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such
excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. 
 Execution
Version 
 WAIVER AND FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT 

THIS WAIVER AND FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”) is entered into as of
August 14, 2019, among Restoration Robotics, Inc., a Delaware corporation (the “Borrower”), Solar Capital Ltd., a Maryland corporation (in its capacity as collateral agent, the “Collateral
Agent”) and the Lenders party hereto, comprising the Required Lenders under the Loan Agreement referred to below (each, a “Lender” and, collectively, the “Lenders”). 

RECITALS 

A. The Borrower, the Lenders party thereto, and the Collateral Agent, are parties to that certain Loan and Security Agreement, dated as of
May 10, 2018, as amended by that certain First Amendment to Loan and Security Agreement, dated as of June 29, 2018, that certain Second Amendment to Loan and Security Agreement, entered into as of November 2, 2018, that certain Third
Amendment to Loan and Security Agreement, dated as of February 13, 2019, and that certain Fourth Amendment to Loan and Security Agreement, dated as of June 14, 2019 (as further amended, supplemented or otherwise modified prior to the date
hereof, the “Loan Agreement”). 
 B. The Borrower has requested certain amendments and waivers to the Loan Agreement.
Although the Lenders and the Collateral Agent are under no obligation to do so, they have agreed to such requests, subject to the terms and conditions hereof. 

AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows: 
 1. Definitions. Capitalized terms used
but not defined in this Agreement shall have the meanings given to them in the Loan Agreement. 
 2. Amendments to the Loan Agreement.
The Loan Agreement shall be amended as follows: 
 2.1 Definition of Final Fee. The definition of “Final Fee” is hereby amended
and restated as follows: 
 “Final Fee” is a payment (in addition to and not a substitution for the regular
monthly payments of principal plus accrued interest or any other fee payable hereunder) (a) due on the earliest to occur of (i) the Maturity Date, (ii) the acceleration of the Term Loan, and (iii) the prepayment in full of the
Term Loans pursuant to Section 2.2(c) or (d), and (b) equal to “(1) if the Obligations are repaid in full on or prior to August 31, 2019, One Million, One Hundred Ten Thousand Dollars ($1,110,000.00), (2) if the Obligations are
repaid in full after August 31, 2019 but on or prior to October 1, 2019, One Million Three Hundred Ten Thousand Dollars ($1,310,000.00), or (3) if the Obligations remain outstanding after October 1, 2019, One Million Four Hundred
Ten Thousand Dollars ($1,410,000.00). The Final Fee shall be fully earned on the date so paid, non-refundable for any reason and payable to the Lenders in accordance with their respective Pro Rata Shares. 

 2.2 Section 6.12. The following shall be added to the end of the
existing Section 6.12 of the Loan Agreement: 
 “In addition, on or before each deadline set forth in the following table, Borrower
shall have provided evidence reasonably satisfactory to the Collateral Agent that Borrower has received after August 12, 2019 and prior to the applicable deadline, at least the aggregate amount set forth in the following table for that deadline
in aggregate unrestricted net cash proceeds from the sale and issuance of Borrower’s common or preferred stock pursuant to one or more bona fide equity financings or the issuance of Subordinated Debt, in each case on terms reasonably acceptable
to Collateral Agent: 
  

					
	 Deadline
	  	Aggregate
Amount After
August 12,
2019	 
	 August 30, 2019
	  	$	3,000,000	 
	 September 30, 2019
	  	$	4,000,000	 
	 October 15, 2019
	  	$	4,500,000”	 

 2.3 Section 6.13. The reference to “July 31, 2019” at the end of the
existing Section 6.13 of the Loan Agreement is hereby deleted and replaced with “September 30, 2019”. 
 2.4
Section 7.13. The reference to “August 31, 2019” in clause (a) of the existing Section 7.13 of the Loan Agreement is hereby deleted and replaced with “October 31, 2019” and the reference to
“September 1, 2019” in clause (b) of the existing Section 7.13 of the Loan Agreement is hereby deleted and replaced with “November 1, 2019”. 

2.5 Section 7.14. The following proviso shall be added and the end of the first sentence of the existing
Section 7.14 of the Loan Agreement: 
 ; provided that the foregoing covenant shall not be tested for the months of July through
October 2019. 
 2.6 Exhibit G. Exhibit G to the Loan Agreement shall be replaced in its entirety with Exhibit A hereto. 

3. Waiver. Each Lender and the Collateral Agent hereby waives the Event of Default that would exist as a consequence of the
Borrower’s failure to comply with each of (i) Section 6.13 of the Loan Agreement (as was in effect as of the date immediately prior to the date hereof) and (ii) Section 7.14 of the Loan Agreement for the period ending
June 30, 2019. 
 4. Conditions to Effectiveness. The effectiveness of Section 2 and
Section 3 shall be subject to the satisfaction of each of the following conditions precedent, each in form and substance reasonably satisfactory to Collateral Agent: 

4.1 the due execution and delivery to the Collateral Agent of this Agreement by each party hereto; 

4.2 the Borrower shall have paid to the Lenders in accordance with their respective Pro Rata Shares an amendment fee of Fifty Thousand Dollars
($50,000.00); and 

  
 2 

 4.3 the Borrower shall have paid to the Lenders the reasonable out-of-pocket costs and expenses of the Collateral Agent and the Lenders party hereto, and the reasonable fees and disbursements of counsel to the Collateral Agent and the
Lenders party hereto, in connection with the negotiation, preparation, execution and delivery of this Agreement and any other documents to be delivered in connection herewith. 

5. Representations and Warranties. The Borrower represents and warrants to the Collateral Agent and each Lender as follows: 

5.1 Each of the representations and warranties made by the Borrower in or pursuant to any Loan Document (a) that is qualified by
materiality is true and correct, and (b) that is not qualified by materiality is true and correct in all material respects, in each case, on and as of the date of this Agreement, except to the extent that any such representation and warranty
specifically relates to an earlier date, in which case such representation and warranty was true and correct in all material respects as of such earlier date. 

5.2 The Borrower has the power and authority to execute and deliver this Agreement and to perform its obligations under the Loan Documents.

 5.3 The execution and delivery by the Borrower of this Agreement, the performance by Borrower of its obligations under the Loan Agreement,
have been duly authorized by all necessary corporate action on the part of the Borrower. 
 5.4 The execution and delivery by the Borrower of
this Agreement and the performance by the Borrower of its obligations hereunder do not (a) conflict with any of the Operating Documents of the Borrower, (b) contravene, conflict with, constitute a default under or violate any material
Requirement of Law applicable to the Borrower, (c) contravene, conflict or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which Borrower or any of its property or assets
may be bound or affected, (d) require any action by, filing, registration, or qualification with, or Governmental Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full
force and effect), or (e) constitute an event of default under any material agreement by which Borrower or any of its properties, is bound. 

5.5 This Agreement has been duly executed and delivered by the Borrower and is the valid and binding obligation of the Borrower, enforceable
against the Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or
affecting creditors’ rights. 
 5.6 Immediately after giving effect to this Agreement, no Default or Event of Default has occurred and
is continuing under the Loan Agreement or the Loan Documents. 
 6. Reaffirmation of Loan Documents. The Borrower hereby grants,
ratifies and reaffirms the security interest in its Collateral granted to the Collateral Agent pursuant to the terms of the Loan Agreement, and also ratifies and reaffirms its obligations under each Loan Document to which it is party, and
acknowledges and agrees that each such Loan Document shall remain in full force and effect after giving effect to the consummation of this Agreement. This Agreement is not a novation and the terms and conditions of this Agreement shall be in
addition to and supplemental to all terms and conditions set forth in the Loan Documents. In the event of any conflict or inconsistency between this Agreement and the terms of any other Loan Document, the terms of this Agreement shall be
controlling, but such other Loan Document shall not otherwise be affected or the rights therein impaired. 

  
 3 

 7. Integration. This Agreement and the other Loan Documents represent the entire
agreement relating to the subject matter of this Agreement and supersede all prior negotiations and agreements with respect to the substance of this Agreement. All prior agreements, understandings, representations, warranties, and negotiations
between the parties about the subject matter of this Agreement and the Loan Documents merge into this Agreement and the Loan Documents 
 8.
Counterparts. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument. 

9. Miscellaneous. 
 9.1
Except as expressly amended pursuant hereto, the Loan Agreement and the other Loan Documents shall remain unchanged and in full force and effect and are hereby ratified and confirmed in all respects. 

9.2 This Agreement shall constitute a Loan Document under the Loan Agreement. 

9.3 Each provision of this Agreement is severable from every other provision in determining the enforceability of any provision. 

9.4 This Agreement is effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to
(a) be a consent to any Agreement, waiver or modification of any term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which the Collateral Agent or any Lender may now have or may have in the future under
or in connection with any Loan Document. 
 9.5 This Agreement and all documents related hereto shall constitute Loan Documents, shall be
construed in connection with and as part of the Loan Documents. 
 10. Governing Law. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS
OF THE PARTIES HERETO SHALL IN ALL RESPECTS BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO THE CONFLICT OF LAWS PRINCIPLES OF SUCH STATE (OTHER THAN SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW)), INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY AND PERFORMANCE, REGARDLESS OF THE LOCATION OF THE COLLATERAL, PROVIDED, HOWEVER, THAT IF THE LAWS OF ANY JURISDICTION OTHER
THAN NEW YORK SHALL GOVERN IN REGARD TO THE VALIDITY, PERFECTION OR EFFECT OF PERFECTION OF ANY LIEN OR IN REGARD TO PROCEDURAL MATTERS AFFECTING ENFORCEMENT OF ANY LIENS IN COLLATERAL, SUCH LAWS OF SUCH OTHER JURISDICTIONS SHALL CONTINUE TO APPLY
TO THAT EXTENT. This Agreement is subject to the provisions of Section 11 of the Loan Agreement relating to jurisdiction, venue, jury trial waiver and judicial reference, which provisions are by this reference incorporated herein,
mutatis mutandis, as if set forth herein in full. 
 [Signature page follows.] 

  
 4 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date first above
written. 
  

			
	THE BORROWER
	
	RESTORATION ROBOTICS, INC.
		
	By	 	 /s/ Mark Hair

		 	Name: Mark Hair
		 	Title: Chief Financial Officer

 [Signature Page to Restoration Robotics Fifth Amendment to LSA] 

 
			
	COLLATERAL AGENT AND LENDER:
	
	SOLAR CAPITAL LTD.
		
	By	 	 /s/ Anthony Storino

		 	Name: Anthony Storino
		 	Title: Authorized Signatory
	
	LENDER:
	
	SCP PRIVATE CREDIT INCOME FUNDS L.P.
		
	By	 	 /s/ Anthony Storino

		 	Name: Anthony Storino
		 	Title: Authorized Signatory
	
	LENDER:
	
	SUNS SPV LLC
		
	By	 	 /s/ Anthony Storino

		 	Name: Anthony Storino
		 	Title: Authorized Signatory

 [Signature Page to Restoration Robotics Fifth Amendment to LSA] 

 
			
	LENDER:
	
	WESTERN ALLIANCE BANK
		
	By	 	 /s/ Lindsay Fouty

		 	Name: Lindsay Fouty
		 	Title: VP, Portfolio Management

 [Signature Page to Restoration Robotics Fifth Amendment to LSA] 

 Exhibit A 

Replacement Exhibit D 

[See attached] 

 EXHIBIT D 

Compliance Certificate 
  

			
	TO:	  	 SOLAR CAPITAL LTD., as Collateral Agent and Lender

WESTERN ALLIANCE BANK, as Lender

		
	FROM:	  	Restoration Robotics, Inc.

 The undersigned authorized officer (“Officer”) of Restoration Robotics, Inc. (“Borrower”),
hereby certifies that in accordance with the terms and conditions of the Loan and Security Agreement dated as of May 10, 2018 by and among Borrower, Collateral Agent, and the Lenders from time to time party thereto (the “Loan
Agreement;” capitalized terms used but not otherwise defined herein shall have the meanings given them in the Loan Agreement), 

(a) Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below; 

(b) There are no Events of Default or events that with the passage of time could result in an Event of Default, except as noted below; 

(c) Except as noted below, all representations and warranties of Borrower stated in the Loan Documents (other than the Warrants) are true and
correct in all material respects on date hereof; provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; and
provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date 

(d) Borrower, and each of Borrower’s Subsidiaries, has timely filed all required tax returns and reports, Borrower, and each of
Borrower’s Subsidiaries, has timely paid all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by Borrower, or Subsidiary, except as otherwise permitted pursuant to the terms of Section 5.8 of the Loan
Agreement; 
 (e) No Liens have been levied or claims made against Borrower or any of its Subsidiaries relating to unpaid employee payroll or
benefits of which Borrower has not previously provided written notification to Collateral Agent and the Lenders. 
 Attached are the required documents, if
any, supporting our certification(s). The Officer, on behalf of Borrower, further certifies that the attached financial statements are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently applied from one
period to the next except as explained in an accompanying letter or footnotes and except, in the case of unaudited financial statements, for the absence of footnotes and subject to year-end and audit
adjustments as to the interim financial statements. 
 Please indicate compliance status since the last Compliance Certificate by circling Yes, No, or
N/A under “Complies” column. 
  

													
	 	  	Reporting Covenant	  	Requirement	    	Actual	    	Complies
	1)	  	Financial statements	  	Monthly within 30 days	    		    	Yes	    	No	    	N/A
							
	2)	  	Annual (CPA Audited) statements	  	Within 180 days after FYE	    		    	Yes	    	No	    	N/A

													
	3)	  	Annual Financial Projections/Budget (prepared on a monthly basis)	  	Annually (within 60 days after FYE or 10 days of approval), and when revised (within 7 days of approval)	    		    	Yes	    	No	    	N/A
							
	4)	  	8-K, 10-K and 10-Q Filings	  	If applicable, within 5 days of filing	    		    	Yes	    	No	    	N/A
							
	5)	  	Compliance Certificate	  	Monthly within 30 days	    		    	Yes	    	No	    	N/A
							
	6)	  	Total amount of Borrower’s unrestricted cash and Cash Equivalents at the last day of the measurement period	  		    	$________	    	Yes	    	No	    	N/A
							
	7)	  	Total amount of Borrower’s Subsidiaries’ unrestricted cash and Cash Equivalents at the last day of the measurement period	  		    	$________	    	Yes	    	No	    	N/A

 Deposit and Securities Accounts 

(Please list all accounts; attach separate sheet if additional space needed) 
  

													
	 Institution Name
	  	Account Number	  	New
Account?	  	Account Control Agreement in place?
	1)	  		  		  	Yes	  	No	  	Yes	  	No
							
	2)	  		  		  	Yes	  	No	  	Yes	  	No
							
	3)	  		  		  	Yes	  	No	  	Yes	  	No
							
	4)	  		  		  	Yes	  	No	  	Yes	  	No

 Financial Covenants 
  

			
	[7.13 – Minimum Liquidity Requirement:	  	
		
	 1. Unrestricted Cash and Cash Equivalents:
	  	_________________]1
		
	 2. Does this comply with the Minimum of $7,500,000 on or prior to October 31, 2019 or $12,500,000
thereafter?
	  	Yes                 No
	
	7.14 – Minimum Revenue Requirement:
		
	 1. Actual 12 month Trailing Revenue for this month:
	  	$ ____________
		
	 2. Does this comply with the Minimum Revenue Required in Column D below for this month:
	  	Yes                 No

  

	1 	 To be included only if applicable. 

							
	A	  	B	  	C	  	D
	 Month Ending
	  	 Management Case Revenue
Projection (12 Month Trailing)
	  	 Minimum Percent Achievement for
Covenant
	  	 Minimum Revenue Required for
Covenant (12 Month
Trailing)

				
	9/30/2018	  	[***]	  	[***]	  	[***]
				
	10/31/2018	  	[***]	  	[***]	  	[***]
				
	11/30/2018	  	[***]	  	[***]	  	[***]
				
	12/31/2018	  	[***]	  	[***]	  	[***]
				
	1/31/2019	  	[***]	  	[***]	  	[***]
				
	2/28/2019	  	[***]	  	[***]	  	[***]
				
	3/31/2019	  	[***]	  	[***]	  	[***]
				
	4/30/2019	  	[***]	  	[***]	  	[***]
				
	5/31/2019	  	[***]	  	[***]	  	[***]
				
	6/30/2019	  	[***]	  	[***]	  	[***]
				
	7/31/2019	  	[***]	  	[***]	  	[***]
				
	8/31/2019	  	[***]	  	[***]	  	[***]
				
	9/30/2019	  	[***]	  	[***]	  	[***]
				
	10/31/2019	  	[***]	  	[***]	  	[***]
				
	11/30/2019	  	[***]	  	[***]	  	[***]
				
	12/31/2019	  	[***]	  	[***]	  	[***]
				
	1/31/2020	  	[***]	  	[***]	  	[***]
				
	2/29/2020	  	[***]	  	[***]	  	[***]
				
	3/31/2020	  	[***]	  	[***]	  	[***]
				
	4/30/2020	  	[***]	  	[***]	  	[***]
				
	5/31/2020	  	[***]	  	[***]	  	[***]
				
	6/30/2020	  	[***]	  	[***]	  	[***]
				
	7/31/2020	  	[***]	  	[***]	  	[***]
				
	8/31/2020	  	[***]	  	[***]	  	[***]
				
	9/30/2020	  	[***]	  	[***]	  	[***]

							
	10/31/2020	  	[***]	  	[***]	  	[***]
				
	11/30/2020	  	[***]	  	[***]	  	[***]
				
	12/31/2020	  	[***]	  	[***]	  	[***]
				
	1/31/2021	  	[***]	  	[***]	  	[***]
				
	2/28/2021	  	[***]	  	[***]	  	[***]
				
	3/31/2021	  	[***]	  	[***]	  	[***]
				
	4/30/2021	  	[***]	  	[***]	  	[***]
				
	5/31/2021	  	[***]	  	[***]	  	[***]
				
	6/30/2021	  	[***]	  	[***]	  	[***]
				
	7/31/2021	  	[***]	  	[***]	  	[***]
				
	8/31/2021	  	[***]	  	[***]	  	[***]
				
	9/30/2021	  	[***]	  	[***]	  	[***]
				
	10/31/2021	  	[***]	  	[***]	  	[***]
				
	11/30/2021	  	[***]	  	[***]	  	[***]
				
	12/31/2021	  	[***]	  	[***]	  	[***]
				
	1/31/2022	  	[***]	  	[***]	  	[***]
				
	2/28/2022	  	[***]	  	[***]	  	[***]
				
	3/31/2022	  	[***]	  	[***]	  	[***]
				
	4/30/2022	  	[***]	  	[***]	  	[***]

 Other Matters 
  

							
	1)	  	Have there been any changes in Key Persons since the last Compliance Certificate?	  	Yes	  	No
				
	2)	  	Have there been any transfers/sales/disposals/retirement of Collateral or IP prohibited by the Loan Agreement?	  	Yes	  	No
				
	3)	  	Have there been any new or pending claims or causes of action against Borrower or any of its Subsidiaries that involve more than Two Hundred Fifty Thousand Dollars ($250,000.00)?	  	Yes	  	No
				
	4)	  	Have there been any amendments of or other changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries? If yes, provide copies of any such amendments or changes with this
Compliance Certificate.	  	Yes	  	No

							
	5)	  	Has Borrower or any Subsidiary entered into any Material Agreement, amended any Material Agreement, or modified any other license, agreement or other contractual arrangement such that it would become a Material Agreement? If yes,
please explain and provide a copy of the Material Agreement(s) and/or amendment(s).	  	Yes	  	No
				
	6)	  	Has Borrower provided the Collateral Agent with all notices required to be delivered under Sections 6.2(a) and 6.2(b) of the Loan Agreement?	  	Yes	  	No

 Exceptions 

Please explain any exceptions with respect to the certification above: (If no exceptions exist, state “No exceptions.” Attach separate sheet if
additional space needed.) 
 Restoration Robotics, Inc. 
  

			
	By:	 	  

	Name:	 	 
	Title:	 	 

 Date: 
  

													
		 		 		 	COLLATERAL AGENT USE ONLY
				
		 	                	 	            	 	Received by:                                
                    Date:             
				
		 		 		 	Verified by:
                                         
           Date:             
				
		 		 		 	Compliance Status:             Yes                 NoExhibit 10.1

 

LOCK-UP AGREEMENT

 

July 11, 2019

 

Oppenheimer & Co. Inc.

As Representative of the Several Underwriters

c/o Oppenheimer & Co. Inc.

85 Broad Street

New York, New York 10004

 

Re: Public Offering of Eyenovia, Inc.

 

Ladies and Gentlemen:

 

The undersigned, an
officer, director and/or holder of common stock, par value $0.0001 per share (“Common Stock”), or rights to
acquire Common Stock, of Eyenovia, Inc. (the “Company”) understands that you, as Representative of the
several Underwriters (the “Representative”), propose to enter into an Underwriting Agreement (the “Underwriting
Agreement”) with the Company, providing for the public offering (the “Public Offering”) by the several
Underwriters named in Schedule I to the Underwriting Agreement (the “Underwriters”), of shares of Common
Stock of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have
the meanings set forth in the Underwriting Agreement.

 

In consideration of
the Underwriters’ agreement to enter into the Underwriting Agreement and to proceed with the Public Offering of the Securities,
and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees for the benefit
of the Company, you and the other Underwriters that, without the prior written consent of the Representative on behalf of the Underwriters,
the undersigned will not, during the period ending 90 days (the “Lock-Up Period”) after the date of the prospectus
relating to the Public Offering (the “Prospectus”), directly or indirectly (1) offer, pledge, assign, encumber,
announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, any shares of Common Stock or any
securities convertible into or exercisable or exchangeable for Common Stock owned either of record or beneficially (as defined
in the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) by the undersigned on the date hereof
or hereafter acquired or (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences
of ownership of the Common Stock, whether any such transaction described in clause (1) or (2) above is to be settled by delivery
of Common Stock or such other securities, in cash or otherwise, or publicly announce an intention to do any of the foregoing. In
addition, the undersigned agrees that, without the prior written consent of the Representative on behalf of the Underwriters, it
will not, during the Lock-Up Period, make any demand for or exercise any right with respect to, the registration of any shares
of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock.

 

     

     

    

 

The restrictions in
the immediately preceding paragraph shall not apply to:

 

		(a)	the sale of the Securities to be sold pursuant to the Underwriting Agreement;

 

(b) transfers of shares
of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock (i) as a bona fide gift, or gifts,
(ii) to an immediate family member or a trust for the direct or indirect benefit of the undersigned or such immediate family member
of the undersigned, (iii) by will or intestacy, or (iv) pursuant to a qualified domestic order or in connection with a divorce
settlement;

 

(c) equity securities
issued pursuant to the Company’s equity incentive plans in effect as of the date hereof or pursuant to bona fide equity incentive
plans hereafter established, and the exercise of options granted under the Company’s equity incentive plans; provided that
the shares of Common Stock delivered upon such exercise are subject to the restrictions set forth in the immediately preceding
paragraph;

 

(d) transfers of shares
of Common Stock to the Company (i) as forfeitures to satisfy tax withholding and remittance obligations of the undersigned in connection
with the vesting or exercise of equity awards granted pursuant to the Company’s equity incentive plans, or (ii) pursuant
to a net exercise or cashless exercise by the stockholder of outstanding equity awards pursuant to the Company’s equity incentive
plans;

 

(e) the establishment
of a trading plan that complies with Rule 10b5-1 under the Exchange Act; provided, however, that (i) the restrictions shall apply
in full force to sales or other dispositions pursuant to such Rule 10b5-1 plan and (ii) no public announcement or disclosure of
entry into such Rule 10b5-1 plan is made or required to be made, including any filing with the SEC under Section 13 or Section
16 of the Exchange Act, in each case during the Lock-Up Period;

 

(f) transfers of shares
of Common Stock to a charity or education institution;

 

(g) if the undersigned
is or, directly or indirectly, controls a corporation, partnership, limited liability company or other business entity, any transfers
of Common Stock to any shareholder, partner or member of, or owner of similar equity interests in, the undersigned, as the case
may be;

 

(h) transactions relating
to the Common Stock acquired in open market transactions after the completion of the Public Offering; and

 

(i) the transfer of
Common Stock pursuant to a change of control of the Company after the Public Offering, that has been approved by the independent
members of the Company’s board of directors, provided, that in the event that such change of control is not completed, the
Securities owned by the undersigned shall remain subject to the restrictions herein. For purposes of this clause (i), “change
of control” shall mean the consummation of any bona fide third party tender offer, merger, consolidation or other similar
transaction made to all holders of Securities the result of which is that any “person” (as defined in Section 13(d)(3)
of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules 13d-3 and 13d-5 of the Exchange Act)
of more than 50% of the voting capital stock of the Company; provided that, in the case of clauses (b), (f), (g) and (h), no filing
under Section 13 or Section 16(a) of the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock
or other public announcement shall be required or voluntarily made by the undersigned or the recipient during the Lock-Up Period
(other than a filing on Form 5 and any required Schedule 13G (or 13G/A) or Form 13F filing); provided further that, in the case
of any transfer or distribution pursuant to clauses (b), (f) and (g), (1) the recipient agrees to be bound in writing by the same
restrictions set forth herein for the duration of the Lock-Up Period and (2) any such transfer shall not involve a disposition
for value.

 

     

     

    

 

In furtherance of the
foregoing, the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein,
are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of
this Lock-Up Agreement.

 

The undersigned hereby
represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement. All authority herein
conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs
or personal representatives of the undersigned.

 

The undersigned understands
that, if (i) the Underwriting Agreement does not become effective and the Company has not consummated a transaction pursuant thereto
by August 13, 2019, (ii) the Company notifies the Underwriters in writing that it does not intend to proceed with the Offering,
or (iii) the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated
prior to payment for and delivery of the Securities to be sold thereunder, then upon the occurrence of any such event, this Lock-Up
Agreement shall immediately be terminated and the undersigned shall be released from all its obligations thereunder.

 

The undersigned, whether
or not participating in the Public Offering, understands that the Underwriters are entering into the Underwriting Agreement and
proceeding with the Public Offering in reliance upon this Lock-Up Agreement.

 

     

     

    

 

This Lock-Up Agreement
shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws
principles thereof.

 

	 	Very truly yours,
	 	 
	 	 	 
	 	Name:	Fred Eshelman
	 	 	 
	 	 	 
	 	By:	/s/ Fred Eshelman

 

[Signature Page to Lock-Up Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]